Unmet Supportive Care Needs in Bladder Cancer Patients Undergoing Radical Cystectomy

Sponsor
University Hospital, Ghent (Other)
Overall Status
Unknown status
CT.gov ID
NCT03307200
Collaborator
(none)
40
1
31.9
1.3

Study Details

Study Description

Brief Summary

Nowadays, high-quality cancer care is more than just diagnosis and treatment of cancer. Healthcare must respond to the specific needs of the patients to provide patient-centered care. To date, research on the unmet supportive care needs in bladder cancer patients undergoing radical cystectomy is scarce. Because the needs of the patients may differ according to the phase in the illness trajectory, it is important that prospective research is carried out. Research in other cancer populations shows that unmet supportive care needs are negatively associated with health-related quality of life, psychological distress, physical activity and the health literacy of the patient. By incorporating the above factors into this study, we can not only map the unmet supportive care needs of the patient, but also explore possible associations between the variables. Since this is the first prospective study on supportive care needs in bladder cancer, this is a hypothesis-generating study.

Condition or Disease Intervention/Treatment Phase

    Study Design

    Study Type:
    Observational
    Anticipated Enrollment :
    40 participants
    Observational Model:
    Cohort
    Time Perspective:
    Prospective
    Official Title:
    A Prospective Observational Study on the Unmet Supportive Care Needs of Bladder Cancer Patients Undergoing Radical Cystectomy
    Actual Study Start Date :
    Apr 3, 2017
    Anticipated Primary Completion Date :
    Dec 1, 2019
    Anticipated Study Completion Date :
    Dec 1, 2019

    Outcome Measures

    Primary Outcome Measures

    1. Change in Unmet supportive care needs [From baseline up to 1 year]

      Assessed with the 34-item supportive care needs survey (SCNS-34)

    Secondary Outcome Measures

    1. Change in Cancer-specific Health-related quality of life [From baseline up to 1 year]

      Assessed with the EORTC-qlq-c30

    2. Change in Bladder cancer-specific Health-related quality of life [From baseline up to 1 year]

      Assessed with the EORTC-qlq-blm30

    3. Change in Psychological distress [From baseline up to 1 year]

      Assessed with the distress thermometer

    4. Change in problems associated with psychological distress [From baseline up to 1 year]

      Assessed with the problem list

    5. Health literacy [Baseline]

      Assessed with the BRIEF Health Literacy Screening Tool

    6. Change in Physical activity pattern [From baseline up to 1 year]

      Assessed with the Godin Leisure-Time Exercise Questionnaire

    7. Change in Physical Activity Stage of change [From baseline up to 1 year]

      Assessed with a questionnaire based on an algorithm made by Marcus et al.

    8. Change in The use of health care services [From baseline up to 1 year]

      Separate questions where the patient is asked about his/her use of supportive health care services.

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years and Older
    Sexes Eligible for Study:
    All
    Inclusion Criteria:
    • age is 18 years or older

    • Patients diagnosed with bladder cancer who will undergo radical cystectomy

    • Patient has to be able to sign informed consent

    Exclusion Criteria:
    • Metastatic cancer

    • Presence of a second primary tumor with the exception of fully deleted prostate cancer, non-melanoma skin tumor or tumor diagnosed ≥ 5 years ago and under control

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Ghent University Ghent Belgium

    Sponsors and Collaborators

    • University Hospital, Ghent

    Investigators

    • Principal Investigator: Valérie Fonteyne, MD, PhD, Gent University

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Radiotherapie, Prof. Dr. Valérie Fonteyne, University Ghent
    ClinicalTrials.gov Identifier:
    NCT03307200
    Other Study ID Numbers:
    • EC/2017/0350
    First Posted:
    Oct 11, 2017
    Last Update Posted:
    Oct 11, 2017
    Last Verified:
    Oct 1, 2017
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Keywords provided by Radiotherapie, Prof. Dr. Valérie Fonteyne, University Ghent
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Oct 11, 2017